Prolonged coma due to amitriptyline overdose and genetic polymorphism: a case report
- PMID: 35296334
- PMCID: PMC8925239
- DOI: 10.1186/s13256-022-03294-x
Prolonged coma due to amitriptyline overdose and genetic polymorphism: a case report
Abstract
Background: Reduced consciousness has a wide variety of possible causes, not infrequently being toxic in nature. An intoxication might be obvious, but in this paper an unexpected case with a tricyclic antidepressant is presented.
Case presentation: A 76-year-old caucasian female was found unconscious. Primary diagnostic evaluation, including a negative drugs of abuse test, did not give direction to any clear cause. Yet an intraventricular conductive disorder with widening of the QRS complex and electroencephalogram abnormalities did suggest a possible drug effect. Heteroanamnestic information led to the suspicion of an amitriptyline intoxication, which was confirmed by further laboratory analysis. The patient remained comatose for several days. High concentrations of amitriptyline indicated a large overdose of amitriptyline and, in combination with a cytochrome P450 2D6 poor metabolizer status, could explain the long persistence of her comatose state.
Conclusion: We present a tricyclic antidepressant intoxication, where the patient is thought to have taken a large amount of amitriptyline at once, which, in combination with a cytochrome P450 2D6 poor metabolizer status, led to an unusual long persistence of her coma.
Keywords: Amitriptyline; Case report; Coma; Intoxication; Metabolizer status; Tricyclic antidepressant.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




References
-
- Mellström B, von Bahr C. Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes. Drug Metab Dispos. 1981;9(6):565–568. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical